The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
972
April 12, 1996
View Complete Issue         Table of Contents 2019 
New Drugs for HIV Infection
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
New Drugs for HIV Infection
April 12, 1996 (Issue: 972)
The US Food and Drug Administration (FDA) has approved the marketing of five new drugs for treatment of HIV Infection. Stavudine (D4T; Zerit - Bristol-Myers Squibb) and lamivudine (3TC; Epivir - Glaxo Wellcome) are nucleoside analogs similar to...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: New Drugs for HIV Infection
Article code: 972a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.